• Wednesday,September 25,2024
ururembotoursandtravel.com
X

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases

$ 25.50

4.5 (594) In stock

Share

Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint Neuro Maestro Brain Model Comparative Reproducibility Error Results Reproducibility error of Maestro (green), FreeSurfer 7.2 (blue) and manual segmentation (red) for common brain structures (left), and average over all structures (right). Bars represent range of measured relative volume difference. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NE
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint

CLPT, ClearPoint Neuro Inc

SEC Filing Voyager Therapeutics Inc.

SNN

SNN

SNN

FORM 10-12G

SNN

SNN

SNN

FDA Clears DyAnsys Neurostimulation Device Primary Relief to Treat Post-Cardiac Surgery Pain

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System

ClearPointNeuro (@ClearPointNeuro) / X

CLS, Clinical Laserthermia Systems AB (ej officiell)